Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
Fabry disease is an X-linked genetic disorder characterized by deficient activity of α-galactosidase A (GLA) and accumulation of glycolipids, and various GLA gene mutations lead to a wide range of clinical phenotypes from the classic form to the later-onset one. To investigate the biochemical hetero...
Main Authors: | Takahiro Tsukimura, Sachie Nakano, Tadayasu Togawa, Toshie Tanaka, Seiji Saito, Kazuki Ohno, Futoshi Shibasaki, Hitoshi Sakuraba |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426914000470 |
Similar Items
-
Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
by: Takahiro Tsukimura, et al.
Published: (2021-09-01) -
Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy
by: Takahiro Tsukimura, et al.
Published: (2020-12-01) -
Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort
by: Hiroki Maruyama, et al.
Published: (2021-06-01) -
Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
by: Hideaki Sueoka, et al.
Published: (2015-01-01) -
Diurnal Variation of Urinary Fabry Disease Biomarkers during Enzyme Replacement Therapy Cycles
by: Michel Boutin, et al.
Published: (2020-08-01)